Drugs / G-CSF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02027220 | Dec 2013 → Dec 2015 | plasma cell myeloma | Second Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02027220 ↗ |
| Action | Inhibit | “G-CSF enhanced bortezomib activity by inhibiting SDF-1/CXCR4” NCT02027220 ↗ |
| Route | Other | “G-CSF Intracutaneous injection (IC)” NCT02027220 ↗ |
| Target | CXCR4 | “G-CSF enhanced bortezomib activity by inhibiting SDF-1/CXCR4” NCT02027220 ↗ |